Business EconomyPosted at: Jun 13 2026 7:01PM


Dr Reddy's launches Generic Bosutinib Tablets in US market

Hyderabad, June 13 (UNI) Dr Reddy's Laboratories Ltd on Saturday announced the launch of Bosutinib Tablets 400 mg, a generic equivalent of Bosulif, in the United States, marking its entry as the first generic player in the market for the strength and further expanding its oncology portfolio.
The Hyderabad-based pharmaceutical major said it has partnered with MSN Laboratories Pvt Ltd. for the product. Under the collaboration, Dr Reddy's holds exclusive marketing rights in the United States, while MSN is responsible for product development and manufacturing.
Bosutinib Tablets 400 mg was a first-to-file product and is eligible for 180 days of generic drug exclusivity in the US market, the company said in a statement.
Commenting on the launch, Milan Kalawadia, Chief Executive Officer, North America, Dr Reddy's Laboratories Inc., said the introduction of the product reflects the company's strategy of ensuring timely market entry for high-priority therapies while improving access to affordable treatment options.
"This launch underscores our commitment to expanding access to critical medicines and strengthening our oncology portfolio while supporting patients and healthcare providers with affordable treatment alternatives," he said.
MSN Laboratories Executive Director Bharat Reddy said the successful development and commercialisation of Bosutinib Tablets highlights the company's scientific, regulatory and manufacturing capabilities in complex oncology products.
"We remain committed to delivering high-quality and affordable medicines globally through efficient product development and manufacturing excellence," he said.
According to IQVIA National Sales Perspectives data, the Bosulif brand of Bosutinib Tablets 400 mg recorded sales of approximately USD 253.8 million in the United States during the 12-month period ended April 2026.
UNI KNR SAS
Please log in to get detailed story.
Tags: #Dr Reddy's launches Generic Bosutinib Tablets in US market
More News

International shipping via Strait of Hormuz declines rapidly post renewed US-Iran clashes

09 Jul 2026 | 10:43 PM

Tehran, Jul 9 (UNI) Global shipping through the Strait of Hormuz has declined sharply following a fresh round of US strikes on Iranian coastal targets.

see more..

NTPC Mines shine in national safety rankings

09 Jul 2026 | 10:28 PM

Ranchi, Jul 9 (UNI) NTPC Mining Limited (NML) has strengthened its position as a leader in mine safety, with three of its coal mines receiving the prestigious 5-star rating in the Star Rating of Open Cast (OC) Coal Mines for the financial year 2024-25, conducted by the Office of the Coal Controller (CCO) under the Ministry of Coal.

see more..

Canara Bank Officials Call on Telangana Governor, Highlight Business Growth

09 Jul 2026 | 8:32 PM

Hyderabad, July 9 (UNI) Senior officials from Canara Bank on Thursday called on Telangana Governor Shiv Pratap Shukla and briefed him on the bank's business growth and key strategic initiatives.

see more..

TCS Q1 FY27 profit rises by 5pc YoY to Rs 13,349 cr

09 Jul 2026 | 7:36 PM

Mumbai, July 9 (UNI) Tata Consultancy Services (TCS) officially announced here on Thursday that it has posted a 5pc year-on-year (YoY) growth in its consolidated net profit at Rs 13,349 crore for the Q1 FY27, as compared to Rs 12,760 crore a year ago.

see more..

Telangana CM calls for development-focused politics, opens Premier Energies Solar Facility

09 Jul 2026 | 7:05 PM

Hyderabad, July 9 (UNI) Telangana Chief Minister A. Revanth Reddy on Thursday said politics should be confined to election periods and the focus should remain on the development of the State.

see more..